| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
8,454 |
1,682 |
$525K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,229 |
4,420 |
$296K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,675 |
2,860 |
$204K |
| 90961 |
|
339 |
335 |
$47K |
| 99354 |
|
329 |
315 |
$41K |
| 94799 |
|
477 |
476 |
$36K |
| 11043 |
|
268 |
64 |
$31K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
729 |
240 |
$28K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
531 |
160 |
$26K |
| 90962 |
|
163 |
163 |
$20K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
246 |
246 |
$19K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
466 |
432 |
$15K |
| 99223 |
Prolong inpt eval add15 m |
174 |
171 |
$14K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
263 |
178 |
$13K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
118 |
30 |
$9K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
98 |
91 |
$9K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
199 |
134 |
$6K |
| H0049 |
Alcohol and/or drug screening |
323 |
297 |
$5K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
311 |
290 |
$4K |
| 94726 |
|
56 |
56 |
$3K |
| 99222 |
Initial hospital care, per day, moderate complexity |
51 |
48 |
$3K |
| 99215 |
Prolong outpt/office vis |
85 |
80 |
$3K |
| 96127 |
|
464 |
436 |
$3K |
| 99406 |
|
193 |
179 |
$3K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
73 |
71 |
$3K |
| 82962 |
|
1,003 |
805 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,217 |
415 |
$2K |
| 99233 |
Prolong inpt eval add15 m |
52 |
13 |
$2K |
| 94010 |
|
56 |
56 |
$2K |
| 99310 |
Prolong nursin fac eval 15m |
18 |
18 |
$933.40 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
51 |
51 |
$492.22 |
| J7050 |
Infusion, normal saline solution, 250 cc |
181 |
29 |
$318.43 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
99 |
12 |
$300.89 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
19 |
12 |
$296.86 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
53 |
33 |
$190.19 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
414 |
218 |
$138.97 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
26 |
13 |
$119.16 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
53 |
49 |
$77.75 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
480 |
357 |
$71.01 |
| 99318 |
|
15 |
15 |
$16.72 |
| 1036F |
|
518 |
483 |
$0.00 |
| 3044F |
|
25 |
24 |
$0.00 |
| 3074F |
|
386 |
358 |
$0.00 |
| 3079F |
|
31 |
28 |
$0.00 |
| 3075F |
|
14 |
13 |
$0.00 |
| 3078F |
|
467 |
426 |
$0.00 |
| 3077F |
|
36 |
33 |
$0.00 |